(Q87527412)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24671665%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

title

[Hypoglycemia and cardiac arrhythmia in patients with diabetes mellitus type 2] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24671665%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference

M Hanefeld

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24671665%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

X Ganz

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24671665%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

C Nolte

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24671665%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

publication date

1 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24671665%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24671665%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24671665%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24671665%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

page(s)

312-319

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24671665%20AND%20SRC:MED&resulttype=core&format=json

Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial

12 March 2020

cites work

1 reference

12 December 2020

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Three-year efficacy of complex insulin regimens in type 2 diabetes

1 reference

12 December 2020

QT dispersion: comparison between diabetic and non-diabetic individuals and correlation with cardiac autonomic neuropathy

1 reference

12 December 2020

Linking the beneficial effects of current therapeutic approaches in diabetes to the vascular endothelin system

1 reference

12 December 2020

Relationship between HbA1c on target, risk of silent hypoglycemia and glycemic variability in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Increased QT dispersion during hypoglycaemia in patients with type 2 diabetes mellitus

1 reference

12 December 2020

Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study

1 reference

12 December 2020

Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it?

1 reference

12 December 2020

Therapy for type 2 diabetes: where do we stand after the UK prospective diabetes study?

1 reference

12 December 2020

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

1 reference

12 December 2020

Reduced capacity of heart rate regulation in response to mild hypoglycemia induced by glibenclamide and physical exercise in type 2 diabetes

1 reference

12 December 2020

Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetes

1 reference

12 December 2020

The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients

1 reference

12 December 2020

Adverse cardiovascular events during treatment with glyburide (glibenclamide) or gliclazide in a high-risk population

1 reference

12 December 2020

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Hypoglycaemia in Type 2 diabetes

1 reference

12 December 2020

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

12 December 2020

Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients.

1 reference

12 December 2020

Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial.

1 reference

12 December 2020

An analysis of early insulin glargine added to metformin with or without sulfonylurea: impact on glycaemic control and hypoglycaemia

1 reference

12 December 2020

Alogliptin after acute coronary syndrome in patients with type 2 diabetes

1 reference

12 December 2020

Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study

1 reference

12 December 2020

Insulin therapy has a complex relationship with measure of oxidative stress in type 2 diabetes: a case for further study

1 reference

12 December 2020

Comparison of basal insulin added to oral agents versus twice-daily premixed insulin as initial insulin therapy for type 2 diabetes

1 reference

12 December 2020

UKPDS and the legacy effect.

1 reference

12 December 2020

Effects of different insulin regimes on postprandial myocardial perfusion defects in type 2 diabetic patients

1 reference

12 December 2020

Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction.

1 reference

12 December 2020

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

1 reference

12 December 2020

Vascular disease and diabetes: is hypoglycaemia an aggravating factor?

1 reference

12 December 2020

[New concepts in the treatment of type 2 diabetes]

1 reference

12 December 2020

Daily insulin doses and injection frequencies of neutral protamine hagedorn (NPH) insulin, insulin detemir and insulin glargine in type 1 and type 2 diabetes: a multicenter analysis of 51 964 patients from the German/Austrian DPV-wiss database

1 reference

12 December 2020

Unraveling the science of incretin biology.

1 reference

12 December 2020

Diabetic autonomic neuropathy

1 reference

12 December 2020

10.1007/S00059-014-4086-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24671665%20AND%20SRC:MED&resulttype=core&format=json

12 March 2020

1 reference